Philadelphia Pharmaceuticals Company

PHIL

JO4121911013

Pharmaceuticals

End-of-day quote Amman S.E. Other stock markets 23:00:00 04/05/2024 BST			5-day change	1st Jan Change
1.36 ^JOD	-1.45%		0.00%	-4.90%

04-25	Philadelphia Pharmaceuticals Company Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-11	Philadelphia Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Philadelphia Pharmaceuticals plc Reports Earnings Results for the Full Year Ended December 31, 2020

June 07, 2021 at 03:08 pm

Philadelphia Pharmaceuticals PLC announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was JOD 7,697.033 million. Operating income was JOD 468.868 million. Net income was JOD 141.712 million.

Latest news about Philadelphia Pharmaceuticals Company

Philadelphia Pharmaceuticals Company Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Philadelphia Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2023	02-11	CI
Philadelphia Pharmaceuticals Company Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23	CI
Philadelphia Pharmaceuticals Company Reports Earnings Results for the Half Year Ended June 30, 2023	27/07/23	CI
Philadelphia Pharmaceuticals Company Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Philadelphia Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2022	08/02/23	CI
Philadelphia Pharmaceuticals PLC Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
Philadelphia Pharmaceuticals PLC Reports Earnings Results for the Nine Months Ended September 30, 2021	24/10/21	CI
Philadelphia Pharmaceuticals plc Reports Earnings Results for the Full Year Ended December 31, 2020	07/06/21	CI
Philadelphia Pharmaceuticals plc Reports Earnings Results for the Half Year Ended June 30, 2020	27/07/20	CI
Philadelphia Pharmaceuticals plc Reports Earnings Results for the Full Year Ended December 31, 2019	09/02/20	CI

Chart Philadelphia Pharmaceuticals Company

Duration

Period

Chart Philadelphia Pharmaceuticals Company

More charts

Company Profile

Philadelphia Pharmaceuticals Industry Company PSC is a Jordan-based company that is engaged in the development, manufacture and marketing of human pharmaceutical products of different therapeutic categories. The Company, through its production facilities and laboratories located in Amman Industrial state, develops and produces a number of products that includes: Semisolid Dosage Forms, such as creams, ointments, lotions, gels and suppositories, as well as Liquid Dosage Forms, which include syrups, suspensions, solutions, nasal, drops, mouth washes and vaginal douches. Furthermore, the Company undertakes the distribution and marketing of a range of healthcare systems, miscellaneous and pharmaceuticals of different international brand names, including alimentary, gastrointestinal systems and respiratory systems. The Company markets its products to the local markets and exports to more than 10 countries in the Middle East and North Africa region.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
PHILADELPHIA PHARMACEUTICALS COMPANY	-4.90%	14.39M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.28%	44.4B
OTSUKA HOLDINGS CO., LTD.	+24.60%	23.03B
SANDOZ GROUP AG	+19.22%	15.14B
CIPLA LIMITED	+12.87%	13.12B
ZYDUS LIFESCIENCES LIMITED	+44.67%	11.85B
ONO PHARMACEUTICAL CO., LTD.	-8.33%	6.99B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.22%	5.52B